Asthma, COPD Inhaler Medication Adherence Trends During COVID-19
Patients with asthma and COPD appear to have increased their adherence to inhaler medications in the wake of the COVID-19 pandemic.
All articles by Britt Gambino
Tobacco Smoke Exposure Limits Benefits of CFTR Modulators in Cystic Fibrosis
Tobacco smoke exposure inhibited the therapeutic benefit of the cystic fibrosis transmembrane conductance regulator modulators in pediatric patients.
Lower Calculated Lung Cancer Risk in Black Patients Eligible for Screening
Compared with white patients, black patients with screen-detected cancers had a lower calculated lung cancer risk, despite having a significantly higher mean 6-year lung cancer risk.
Different Phenotypes in COVID-19 Pneumonia Proposed
Patients with COVID-19 pneumonia may present with 2 distinct phenotypes, each warranting distinct treatments.
Fibrosis Indicators May Signal Poor Prognosis Early in COVID-19 Course
Fibrosis indicators, including lymphocyte count and C-reactive protein, may be used as early warning signs of poor prognosis in patients with COVID-19.
RA Conduit Phase Emptying May Predict Adverse Event Risk in Pediatric PAH
Right atrial conduit phase emptying may predict the risk for adverse clinical events in pediatric patients with pulmonary arterial hypertension.
Routine Testing for Non-SARS-CoV-2 Pathogens May Not Rule Out COVID-19
Routine testing for non-SARS-CoV-2 pathogens is unlikely to provide clinical benefit unless a positive result would alter the disease management.
COPD Associated With Significantly Increased Risk for Severe COVID-19
Chronic obstructive pulmonary disease is associated with a greater than 5-fold increased risk for severe coronavirus disease 2019 infection.
SCCM Former Chancellor of Board of Regents on Sharing Ventilators During COVID-19 Pandemic
A joint statement issued by the Society of Critical Care Medicine and several other medical societies has advised against the use of 1 ventilator for multiple patients.
Lopinavir-Ritonavir Does Not Offer Substantial Benefit in Severe COVID-19
In patients who were hospitalized with severe coronavirus disease, treatment with lopinavir-ritonavir did not provide a substantial benefit beyond standard care.
Next post in Lung Infection
